Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

The burden of patent ductus arteriosus (PDA) continues to be significant. In view of marked
differences in preterm infants versus more mature, term counterparts (viewed on a …

Although major breakthroughs in the field of pediatric cardiology, cardiac surgery,
intervention, and overall care improved the outlook of congenital heart disease …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

Abstract Purpose of Review To analyze the pathophysiologic importance of the right heart in
different types of congenital heart disease (CHD), summarize current diagnostic modalities …

Backgrounds Pulmonary arterial hypertension (PAH) is characterized by progressive
pulmonary vascular functional and structural changes, resulting in increased pulmonary …

Eisenmenger syndrome (ES) develops in association with unrepaired, non-restrictive
cardiac shunt lesions at the atrial, ventricular or arterial level over time. In developed …

Patients with unrepaired congenital heart disease (CHD) are prone to pulmonary arterial
hypertension (PAH). The ovine pulmonary arterial smooth muscle cells exposed to …

Haemoptysis represents one of the most severe major bleeding manifestations in the clinical
course of pulmonary arterial hypertension (PAH) associated with congenital heart disease …

Nowadays, most patients with congenital heart disease survive to adulthood due to
advances in pediatric cardiac surgery but often present with various comorbidities and long …